Home » Topics » BioWorld Science

BioWorld Science
RSS

Ocular Therapeutix doses first patient in phase I clinical trial of OTX-TIC

May 4, 2018

FDA grants two fast track designations for 5F9

May 4, 2018

RBH-61, a dual SEH/PDE inhibitor for inflammatory pain

May 4, 2018

Phase I results reported for analgesic CCR2 antagonist CNTX-6970

May 4, 2018

Abbisko presents novel candidates with promising preclinical profiles

May 4, 2018

Daiichi Sankyo profiles highlights of fourth quarter of fiscal 2017

May 4, 2018

Coherus BioSciences announces re-submission of BLA for CHS-1701

May 4, 2018

Azitra raises new financing to advance pipeline

May 4, 2018

Refuge Biotechnologies completes series B financing

May 4, 2018

FDA grants orphan drug designation to BN-Brachyury as treatment for chordoma

May 4, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...